Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations
- PMID: 32752183
- PMCID: PMC7436188
- DOI: 10.3390/molecules25153523
Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations
Abstract
Cranberry (Vaccinium macrocarpon) is a distinctive source of polyphenols as flavonoids and phenolic acids that has been described to display beneficial effects against urinary tract infections (UTIs), the second most common type of infections worldwide. UTIs can lead to significant morbidity, especially in healthy females due to high rates of recurrence and antibiotic resistance. Strategies and therapeutic alternatives to antibiotics for prophylaxis and treatment against UTIs are continuously being sought after. Different to cranberry, which have been widely recommended in traditional medicine for UTIs prophylaxis, probiotics have emerged as a new alternative to the use of antibiotics against these infections and are the subject of new research in this area. Besides uropathogenic Escherichia coli (UPEC), the most common bacteria causing uncomplicated UTIs, other etiological agents, such as Klebsiellapneumoniae or Gram-positive bacteria of Enterococcus and Staphylococcus genera, seem to be more widespread than previously appreciated. Considerable current effort is also devoted to the still-unraveled mechanisms that are behind the UTI-protective effects of cranberry, probiotics and their new combined formulations. All these current topics in the understanding of the protective effects of cranberry against UTIs are reviewed in this paper. Further progresses expected in the coming years in these fields are also discussed.
Keywords: A-type proanthocyanidins; UPEC; UTIs; antiadhesive activity; cranberry; flavan-3-ols; phenolic metabolites; probiotics; urinary tract infections; uropathogenic Escherichia coli.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract?J Ethnopharmacol. 2020 Jul 15;257:112889. doi: 10.1016/j.jep.2020.112889. Epub 2020 Apr 18. J Ethnopharmacol. 2020. PMID: 32311481 Clinical Trial.
-
Cranberry Consumption Against Urinary Tract Infections: Clinical Stateof- the-Art and Future Perspectives.Curr Pharm Biotechnol. 2018;19(13):1049-1063. doi: 10.2174/1389201020666181206104129. Curr Pharm Biotechnol. 2018. PMID: 30520372 Review.
-
Cranberry Polyphenols and Prevention against Urinary Tract Infections: New Findings Related to the Integrity and Functionality of Intestinal and Urinary Barriers.J Agric Food Chem. 2024 May 8;72(18):10328-10338. doi: 10.1021/acs.jafc.3c07169. Epub 2024 Apr 23. J Agric Food Chem. 2024. PMID: 38651941 Free PMC article.
-
In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.J Agric Food Chem. 2015 Oct 14;63(40):8804-18. doi: 10.1021/acs.jafc.5b03030. Epub 2015 Sep 29. J Agric Food Chem. 2015. PMID: 26330108 Clinical Trial.
-
Cranberry and urinary tract infections.Drugs. 2009;69(7):775-807. doi: 10.2165/00003495-200969070-00002. Drugs. 2009. PMID: 19441868 Review.
Cited by
-
Comparative In Vitro Study: Assessing Phytochemical, Antioxidant, Antimicrobial, and Anticancer Properties of Vaccinium macrocarpon Aiton and Vaccinium oxycoccos L. Fruit Extracts.Pharmaceutics. 2024 May 29;16(6):735. doi: 10.3390/pharmaceutics16060735. Pharmaceutics. 2024. PMID: 38931857 Free PMC article.
-
Procyanidins from Cranberry Press Residues-Extraction Optimization, Purification and Characterization.Plants (Basel). 2022 Dec 14;11(24):3517. doi: 10.3390/plants11243517. Plants (Basel). 2022. PMID: 36559628 Free PMC article.
-
Randomized, placebo-controlled, double-blinded study of prophylactic cranberries use in women with recurrent uncomplicated cystitis.World J Urol. 2024 Jan 12;42(1):27. doi: 10.1007/s00345-023-04741-0. World J Urol. 2024. PMID: 38214795 Clinical Trial.
-
Potential of Flavonoids as Promising Phytotherapeutic Agents to Combat Multidrug-Resistant Infections.Curr Pharm Biotechnol. 2024;25(13):1664-1692. doi: 10.2174/0113892010271172231108190233. Curr Pharm Biotechnol. 2024. PMID: 38031767 Review.
-
Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins.Molecules. 2022 Nov 30;27(23):8353. doi: 10.3390/molecules27238353. Molecules. 2022. PMID: 36500445 Free PMC article. Review.
References
-
- Baron E.J., Miller J.M., Weinstein M.P., Richter S.S., Gilligan P.H., Thomson R.B., Bourbeau P., Carroll K.C., Kehl S.C., Dunne W.M., et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) a. Clin. Infect. Dis. 2013;57:22–121. doi: 10.1093/cid/cit278. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical